A Phase III, adjudicator-blinded, randomised study toevaluate the efficacy and safety of treatment with olorofimversus treatment with AmBisome? followed by standard ofcare (SOC) in patients with invasive fungal disease (IFD)caused by Aspergillus spec

Project: Research project

Project Details

Description

A Phase III, adjudicator-blinded, randomised study to evaluate the efficacy and safety of treatment with olorofim versus treatment with AmBisome? followed by standard of care (SOC) in patients with invasive fungal disease (IFD) caused by Aspergillus spec
StatusActive
Effective start/end date1/19/23 → 1/31/28

Funding

  • F2G LTD

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint